Physician profile
Arash Farhadi
NPI 1467619601
$9,487.42
in general payments reported to CMS, 2019-2025
68 companies · $2,643 in 2025
The $2,643 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $333 · 2021: $55.04 · 2022: $876 · 2023: $1,595 · 2024: $2,229 · 2025: $2,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,368 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,367.61 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,292.46 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $689.90 | 2019-2025 | |
| Pfizer INC. | $652.82 | 2023-2025 | |
| Biogen, INC. | $591.86 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Lilly USA, LLC | $470.59 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Teva Pharmaceuticals USA, INC. | $456.59 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Amgen INC. | $378.89 | 2019-2025 | Uplizna |
| Lundbeck LLC | $354.70 | 2019-2025 | Vyepti |
| Harmony Biosciences LLC | $291.10 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $275.45 | 2023-2025 | |
| Grifols USA, LLC | $258.08 | 2019-2025 | Gamunex-C |
| Eisai INC. | $246.47 | 2022-2025 | |
| Celgene Corporation | $240.86 | 2022-2025 | Zeposia |
| Genentech USA, INC. | $199.57 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Neurelis, INC. | $183.94 | 2023-2025 | Valtoco |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Farhadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.